Benefits of imaging in therapeutic management of sarcoidosis;Apport de l'imagerie dans la prise en charge thérapeutique de la sarcoïdose

Revue du Praticien

Volumn 58, Issue 10, 2008, Pages 1081-1087

  Brauner, Michel ^a   Brillet, Pierre Yves ^a   Dumas, Jean Luc ^a   Nunes, Hilario ^a   Valeyre, Dominique ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; GADOLINIUM;

CORTICOSTEROID THERAPY; DIAGNOSTIC IMAGING; HEART DISEASE; HUMAN; LUNG SARCOIDOSIS; MEDICAL DECISION MAKING; PARANASAL SINUS DISEASE; PROGNOSIS; RADIODENSITOMETRY; REVIEW; SARCOIDOSIS; THORAX RADIOGRAPHY;

DIAGNOSTIC IMAGING; HUMANS; SARCOIDOSIS;

EID: 44949138871     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-55.
2. Nunes H, Soler P, Valeyre D. Pulmonary sarcoidosis. Allergy 2005;60:565-82.
3. Nunes H, Brillet PY, Valeyre D, Brauner MW, Wells AU. Imaging in sarcoidosis. Semin Respir Crit Care Med 2007;28:102-20.
4. Baughman RP, Lower EE, du Bois R. Sarcoidosis. Lancet 2003;361:1111-8.
5. Paramothayan S, Jones PW. Corticosteroid therapy in pulmonary sarcoidosis. JAMA 2002;287:1301-7.
6. Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax 1996;51:238-47.
7. Viskum K, Vestbo J. Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur Respir J 1993;6:349-53.
8. Brauner MW, Lenoir S, Grenier P, Cluzel P, Battesti JP, Valeyre D. Pulmonary sarcoidosis: CT assessment of lesion reversibility. Radiology 1992;182:349-54.
9. Remy-Jardin M, Giraud F, Remy J, Wattine L, Wallaert B, Duhamel A. Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology 1994;191:675-80.
10. Murdoch J, Muller NI. Pulmonary sarcoidosis: changes on follow-up CT examination. AJR Am J Roentgenol;1992;159:473-7.
11. Akira M, Kozuka T, Inoue Y, Sakatani M. Long-term follow-up CT scan evaluation in patients with pulmonary sarcoidosis. Chest 2005;127:185-91.
12. Abehsera M, Valeyre D, Grenier P, Jaillet H, Battesti JP, Brauner MW. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am J Roentgenol 2000;174:1751-7.
13. Hennebicque AS, Nunes H, Brillet PY, Moulahi H, Valeyre D, Brauner MW. CT findings in severe thoracic sarcoidosis.Eur Radiol 2005;15:23-30.
14. Dumas JL, Valeyre D, Chapelon-Abric C, et al. Central nervous system sarcoidosis: follow-up and MR imaging during steroid therapy. Radiology 2000;214:411-20.
15. Christoforidis GA, Spickler EM, Recio MV, Mehta BM. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. AJNR Am J Neuroradiol 1999;20:655-69.
16. Chapelon C, Ziza JM, Piette JC, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine 1990;69:261-76.
17. Fels C, Riegel A, Javaheripour-Otto K, Obenauer S. Neurosarcoidosis: findings in MRI. Clin Imaging 2004;28:166-9.
18. Bihan H, Christozova Y, Dumas JL, et al. Sarcoidosis: clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamic-pituitary disease in 9 patients and review of the literature. Medicine (Baltimore) 2007;86:259-68.
19. Le Guludec D, Menad F, Faraggi M, Weinmann P, Battesti JP, Valeyre D. Myocardial sarcoidosis. Clinical value of technetium-99m Sestamibi tomoscintigraphy. Chest 1994;106:6:1675-82.
20. Smedema JP, Snoep G, van Kroonenburgh MP, et al. The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 2005;128:1629-37.
21. Shimada T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001;110:520-7.
22. Vignaux O, Dhote R, Duboc D, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 2002;122:1895-1901.
23. Mana J. Magnetic resonance imaging and nuclear imaging in sarcoidosis. Curr Opin Pulm Med 2002;8:457-63.
24. Doughan AR, Williams BR. Cardiac sarcoidosis. Heart 2006;92:282-8.
25. Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med 2003;44:1030-6.
26. Aubart FC, Ouayoun M, Brauner M, et al. Sinonasal involvement in sarcoidosis: a case-control study of 20 patients. Medicine (Baltimore) 2006;85:365-71.